Major Biotechs See Rising Tide in Short Interest
The October 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
The October 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Credit Suisse and Merrill Lynch made calls in the biotech and pharmaceutical space last week, ahead of coming earnings reports.
Thursday's top analyst upgrades, downgrades and initiations included Abbott Laboratories, CSX, IBM, Netflix, Occidental Petroleum, Whiting Petroleum, Amgen, Gilead Sciences, Merck and Pfizer.
These five Raymond James analyst favorite stock picks have substantial upside potential to the price targets and would make solid portfolio additions at current price levels.
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The September 30 short interest data has been compared with the previous report, and short interest in most…
The September 13 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
The August 30 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
The August 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Here are 30 stocks with sustainable dividends for income investors to consider in their portfolios.
24/7 Wall St. has evaluated all pharmaceutical and biotech companies that pay dividend yields above 2% based on their current prices.
The July 31 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Stocks saw profit-taking on Tuesday, but the major indexes were up on Wednesday ahead of the Federal Reserve’s expected interest rate cut in the afternoon. Earnings season is proving to be quite…
The top analyst upgrades, downgrades and initiations seen on Monday included Aflac, Apple, Chipotle Mexican Grill, Coca-Cola, Dell Technologies, Dish Network, Gilead Sciences, McDonald's and Starbucks.
The July 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Gilead and Galapagos each saw shares shoot up on Monday after the companies announced a new collaboration.